PathAI Integrates PathExplore on AISight Platform for Tumor Analysis
The self-service integration enables users to analyze tumor microenvironments at single-cell resolution using routine H&E slides.
Read MorePosted by CLP Edit Staff | Nov 21, 2025 | Digital Pathology |
The self-service integration enables users to analyze tumor microenvironments at single-cell resolution using routine H&E slides.
Read MorePosted by CLP Edit Staff | Nov 20, 2025 | Prostate |
The whole-genome test combines data from 7 million genetic markers with clinical risk factors to provide individualized 10-year and lifetime risk assessments.
Read MorePosted by CLP Edit Staff | Nov 20, 2025 | Mass Spectrometry |
The system is designed to handle more than 10,000 injections without cleaning and scan over 900 SRM transitions per second for high-throughput laboratories.
Read MorePosted by CLP Edit Staff | Nov 18, 2025 | Womens Health |
The molecular diagnostic system can identify complicated UTI pathogens and antibiotic resistance markers at the point-of-care in approximately 15 minutes.
Read MorePosted by CLP Edit Staff | Nov 17, 2025 | Cervical (HPV) |
The BD Onclarity HPV Assay detects 14 high-risk HPV types and supports self-collection.
Read More